Brief: Rafael Holdings And Cyclo Therapeutics Enter Into A Definitive Merger Agreement
Aug 22 (Reuters) - Cyclo Therapeutics Inc CYTH.O :
* RAFAEL HOLDINGS AND CYCLO THERAPEUTICS ENTER INTO A
DEFINITIVE
MERGER AGREEMENT
* RAFAEL HOLDINGS INC - TO ISSUE CLASS B STOCK TO CYCLO
SHAREHOLDERS
* RAFAEL HOLDINGS: INTENDS TO FUND TRANSPORTNPC CLINICAL
TRIAL TO
48-WEEK INTERIM ANALYSIS
* RAFAEL HOLDINGS: PROPOSED DEAL FOR CYCLO THERAPEUTICS
SHARES AT
$0.95 PER SHARE
Source text for Eikon: ID:nBw3XdH8Ga
Further company coverage: CYTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cyclo Therapeutics
See all newsBrief: Rafael Holdings Completes Merger With Cyclo Therapeutics Following Shareholder Approvals
Cyclo Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Cyclo Therapeutics Inc Issues $2.5 Million Convertible Promissory Note To Rafael Holdings
U.S. STOCKS ON THE MOVE-McDonald, Uber, SolarWinds
Cyclo Therapeutics jumps on prelim late-stage data of genetic disorder drug